Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
about
|
my BioMed Central
Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells.
Li Y, Hussain M, Sarkar SH, Eliason J, Li R, Sarkar FH
BMC Cancer
2005 Jan 18,
5
:7
[
Full text
]
[
PubMed
]
[
Related articles
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 2 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
PubMed Central articles that cite the above article:
1.
Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer.
Friedman J, Dunn RL, Wood D, Vaishampayan U, Wu A, Bradley D, Montie J, Sarkar FH, Shah RB, Hussain M
J Urol
2008 Mar,
179
:911-5; discussion 915-6
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
2.
d -Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis.
Rabi T, Bishayee A
J Carcinog
2009,
8
:9
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
You can also
check ISI Web of Science
for additional citations (subscription required)
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 2 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of
Springer Science+Business Media
.